Allergy-Cancer-BioNano Research Centre
The Allergy Cancer BioNano Research Centre (ACBN) is the largest of three Excellence Clusters for Research within the University of Salzburg. The immune system is in focus of ACBN, where all three topics are connected: Immune reactions are overshooting in allergy, are insufficient or inappropriate in cancer and they are the main reason why nanoparticles are tolerated or defended against. The three topics are further linked by scientific and methodic approaches, resulting in strong cooperation and synergy harvesting within ACBN.
ACBN was originally founded in 2003 under the name “BioScience and Health”, so if you remember this unit, it’s the same as ACBN. Over the years, the centre has expanded both in size and in scope, developing from within ACBN for example the bio/nano issue and integrating groups from the material sciences in the initially purely biological centre. The excellence of ACBN is evaluated every five years, with the last evaluation taking place in 2013 and next coming up in 2018. We gratefully acknowledge the substantial support that the University has given to ACBN since its start in 2003.
University of Salzburg
Department of Molecular Biology
Division of Allergy and Immunology
Tel.: +43 (0)662 8044 5730
+43 (0)662 8044 5577
Fax: +43 (0)662 8044 5751
The picture “Leonardo” was made exclusively for the “ Allergy-Cancer-BioNano Research Centre” by Jutta Duschl.